Dopamine transporter regulates the enhancement of novelty processing by a negative emotional context

Neuropsychologia

Volumn 48, Issue 5, 2010, Pages 1483-1488

  Garcia Garcia, Manuel ^a   Clemente, Immaculada ^a   Domínguez Borràs, Judith ^a   Escera, Carles ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Distraction; Dopamine; Emotional context; Emotional modulation; Novelty P3; SLC6A3 DAT1

Indexed keywords

DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; MEMBRANE PROTEIN; PROTEIN SLC6A3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; EMOTION; EVENT RELATED POTENTIAL; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN;

ADOLESCENT; ADULT; AFFECT; AUDITORY PERCEPTION; DNA PRIMERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; SOCIAL ENVIRONMENT; YOUNG ADULT;

EID: 77949775596     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2010.01.018     Document Type: Article

References (52)

1. Badgaiyan R.D., Fischman A.J., Alpert N.M. Dopamine release during human emotional processing. NeuroImage 2009, 47(4):2041-2045. 10.1016/j.neuroimage.2009.06.008.
2. Barcelo F., Perianez J.A., Nyhus E. An information theoretical approach to task-switching: Evidence from cognitive brain potentials in humans. Frontiers in Human Neuroscience 2007, 1:13. 10.3389/neuro.09.013.2007.
3. Bellgrove M.A., Hawi Z., Kirley A., Gill M., Robertson I.H. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: Sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 2005, 43(13):1847-1857. 10.1016/j.neuropsychologia.2005.03.011.
4. Belouchrani, Abed-Meraim, Cardoso, Moulines A blind source seperation technique using second-order statistics. IEEE Transactions on Signal Processing 1997, 45(2):434-444.
5. Bertolino A., Blasi G., Latorre V., Rubino V., Rampino A., Sinibaldi L., et al. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2006, 26(15):3918-3922. 10.1523/JNEUROSCI.4975-05.2006.
6. Biederman J., Kim J.W., Doyle A.E., Mick E., Fagerness J., Smoller J.W., et al. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: A preliminary study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B(8):1511-1518. 10.1002/ajmg.b.30874.
7. Blackburn J.R., Phillips A.G. Enhancement of freezing behaviour by metoclopramide: Implications for neuroleptic-induced avoidance deficits. Pharmacology, Biochemistry, and Behavior 1990, 35(3):685-691.
8. Bowers D., Miller K., Mikos A., Kirsch-Darrow L., Springer U., Fernandez H., et al. Startling facts about emotion in parkinson's disease: Blunted reactivity to aversive stimuli. Brain: A Journal of Neurology 2006, 129(Pt 12):3356-3365. 10.1093/brain/awl301.
9. Bradley M.M., Codispoti M., Lang P.J. A multi-process account of startle modulation during affective perception. Psychophysiology 2006, 43(5):486-497. 10.1111/j.1469-8986.2006.00412.x.
10. Caldu X., Vendrell P., Bartres-Faz D., Clemente I., Bargallo N., Jurado M.A., et al. Impact of the COMT Val108/158 met and DAT genotypes on prefrontal function in healthy subjects. NeuroImage 2007, 37(4):1437-1444. 10.1016/j.neuroimage.2007.06.021.
11. Camps M., Cortes R., Gueye B., Probst A., Palacios J.M. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites. Neuroscience 1989, 28(2):275-290.
12. Dominguez-Borras J., Garcia-Garcia M., Escera C. Emotional context enhances auditory novelty processing: Behavioural and electrophysiological evidence. The European Journal of Neuroscience 2008, 28(6):1199-1206. 10.1111/j.1460-9568.2008.06411.x.
13. Dominguez-Borras J., Garcia-Garcia M., Escera C. Negative emotional context enhances auditory novelty processing. Neuroreport 2008, 19(4):503-507. 10.1097/WNR.0b013e3282f85bec.
14. Dominguez-Borras J., Trautmann S.A., Erhard P., Fehr T., Herrmann M., Escera C. Emotional context enhances auditory novelty processing in superior temporal gyrus. Cerebral Cortex (New York, N.Y.: 1991) 2008, 10.1093/cercor/bhn188.
15. Escera C., Alho K., Schroger E., Winkler I. Involuntary attention and distractibility as evaluated with event-related brain potentials. Audiology and NeuroOtology 2000, 5(3-4):151-166.
16. Escera C., Alho K., Winkler I., Naatanen R. Neural mechanisms of involuntary attention to acoustic novelty and change. Journal of Cognitive Neuroscience 1998, 10(5):590-604.
17. Escera C., Corral M.J. Role of mismatch negativity and novelty-P3 in involuntary auditory attention. Journal of Psychophysiology 2007, 21(3-4). 251-251-264.
18. Escera C., Yago E., Alho K. Electrical responses reveal the temporal dynamics of brain events during involuntary attention switching. The European Journal of Neuroscience 2001, 14(5):877-883.
19. Escera C., Yago E., Corral M.J., Corbera S., Nunez M.I. Attention capture by auditory significant stimuli: Semantic analysis follows attention switching. The European Journal of Neuroscience 2003, 18(8):2408-2412.
20. Fossella J., Sommer T., Fan J., Wu Y., Swanson J.M., Pfaff D.W., et al. Assessing the molecular genetics of attention networks. BMC Neuroscience 2002, 3:14.
21. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3: An event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neuroscience and Biobehavioral Reviews 2001, 25(4):355-373.
22. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. The Pharmacogenomics Journal 2001, 1(2):152-156.
23. Garcia-Garcia M., Dominguez-Borras J., SanMiguel I., Escera C. Electrophysiological and behavioral evidence of gender differences in the modulation of distraction by the emotional context. Biological Psychology 2008, 79(3):307-316. 10.1016/j.biopsycho.2008.07.006.
24. Garcia-Garcia, M., Barcelo, F., Clemente, I.C. & Escera, C. (in press). The role of dopamine transporter DAT1 genotype on the neural correlates of cognitive flexibility. European Journal of Neuroscience.
25. Garcia-Garcia M., Yordanova J., Kolev V., Dominguez-Borras J., Escera C. Tuning the brain for novelty detection under emotional threat: The role of increasing gamma phase-synchronization. NeuroImage 2010, 49(1):1038-1044. 10.1016/j.neuroimage.2009.07.059.
26. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2000, 22(2):133-139. 10.1016/S0893-133X(99)00099-8.
27. Jacobsen L.K., Staley J.K., Zoghbi S.S., Seibyl J.P., Kosten T.R., Innis R.B., et al. Prediction of dopamine transporter binding availability by genotype: A preliminary report. The American Journal of Psychiatry 2000, 157(10):1700-1703.
28. Kahkonen S., Ahveninen J., Pekkonen E., Kaakkola S., Huttunen J., Ilmoniemi R.J., et al. Dopamine modulates involuntary attention shifting and reorienting: An electromagnetic study. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 2002, 113(12):1894-1902.
29. Lang P.J. Behavioral treatment and bio-behavioral assessment: Computer applications. Technology in mental health care delivery systems 1980, Ablex, Norwood, NJ, 119-119-137. J.B. Sidowski, J.H. Johnson, T.A. Williams (Eds.).
30. Lang P.J., Bradley M.M., Cuthbert B.N. International affective picture system (IAPS): Affective ratings of pictures and instruction manual 2005, University of Florida, Gainesville, FL.
31. Lawrence A.D., Goerendt I.K., Brooks D.J. Impaired recognition of facial expressions of anger in parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia 2007, 45(1):65-74. 10.1016/j.neuropsychologia.2006.04.016.
32. Lewis D.A., Melchitzky D.S., Sesack S.R., Whitehead R.E., Auh S., Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization. The Journal of Comparative Neurology 2001, 432(1):119-136.
33. Mehta M.A., Hinton E.C., Montgomery A.J., Bantick R.A., Grasby P.M. Sulpiride and mnemonic function: Effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers. Journal of Psychopharmacology (Oxford, England) 2005, 19(1):29-38. 10.1177/0269881105048889.
34. Mill J., Asherson P., Browes C., D'Souza U., Craig I. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. American Journal of Medical Genetics 2002, 114(8):975-979. 10.1002/ajmg.b.10948.
35. Miller K.M., Okun M.S., Marsiske M., Fennell E.B., Bowers D. Startle reflex hyporeactivity in parkinson's disease: An emotion-specific or arousal-modulated deficit?. Neuropsychologia 2009, 47(8-9):1917-1927. 10.1016/j.neuropsychologia.2009.03.002.
36. Montague P.R., Hyman S.E., Cohen J.D. Computational roles for dopamine in behavioural control. Nature 2004, 431(7010):760-767. 10.1038/nature03015.
37. Monte-Silva K., Kuo M.F., Thirugnanasambandam N., Liebetanz D., Paulus W., Nitsche M.A. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2009, 29(19):6124-6131. 10.1523/JNEUROSCI.0728-09.2009.
38. Nader K., LeDoux J.E. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behavioral Neuroscience 1999, 113(5):891-901.
39. Nagel I.E., Chicherio C., Li S.C., von Oertzen T., Sander T., Villringer A., et al. Human aging magnifies genetic effects on executive functioning and working memory. Frontiers in Human Neuroscience 2008, 2:1. 10.3389/neuro.09.001.2008.
40. O'Reilly R.C., Braver T.S., Cohen J.D. Mechanisms of active maintenance and executive control. Models of working memory 1999, Cambridge Univ Press, New York. A. Miyake, P. Shah (Eds.).
41. Potts G.F., Martin L.E., Burton P., Montague P.R. When things are better or worse than expected: The medial frontal cortex and the allocation of processing resources. Journal of Cognitive Neuroscience 2006, 18(7):1112-1119. 10.1162/jocn.2006.18.7.1112.
42. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Toulopoulou T., Bramon E., et al. Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(32):13600-13605. 10.1073/pnas.0903007106.
43. Sano A., Kondoh K., Kakimoto Y., Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Human Genetics 1993, 91(4):405-406.
44. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1998, 18(7):2697-2708.
45. Spielberger C.D., Gorsuch R.L., Lushene P.R., Vagg P.R., Jacobs A.G. Manual for the state-trait anxiety inventory (form Y) 1983, Consulting Psychologists Press, Inc, Palo Alto.
46. Stanley J., Knight R.G. Emotional specificity of startle potentiation during the early stages of picture viewing. Psychophysiology 2004, 41(6):935-940. 10.1111/j.1469-8986.2004.00242.x.
47. Swanson J., Posner M., Fusella J., Wasdell M., Sommer T., Fan J. Genes and attention deficit hyperactivity disorder. Current Psychiatry Reports 2001, 3(2):92-100.
48. Troiano A.R., Schulzer M., de la Fuente-Fernandez R., Mak E., McKenzie J., Sossi V., et al. Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function. Synapse (New York, N.Y.) 2010, 64(2):146-151. 10.1002/syn.20708.
49. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992, 14(4):1104-1106.
50. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genetics 2005, 6:55. 10.1186/1471-2156-6-55.
51. Wichmann T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Current Opinion in Neurobiology 1996, 6(6):751-758.
52. Zink C.F., Pagnoni G., Chappelow J., Martin-Skurski M., Berns G.S. Human striatal activation reflects degree of stimulus saliency. NeuroImage 2006, 29(3):977-983. 10.1016/j.neuroimage.2005.08.006.